(Q33770362)
Statements
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy (English)
Charles J Ryan
Matthew R Smith
Lawrence Fong
Jonathan E Rosenberg
Vanessa Martins
Gloria Lee
Thian Kheoh
Jennifer Kim
16 February 2010